Joann Ginal
- Democratic
- Senator
- District 14
Primary
Current law requires the Colorado prescription drug affordability review board (board) to take certain measures in determining whether to conduct an affordability review for an identified prescription drug. The act requires the board, in making such a determination, to consider whether the drug has an approved orphan drug designation for one or more rare diseases and no other indications and, if so, to consider input from consumers and the Colorado rare disease advisory council (council). Current law requires the board, in performing an affordability review, to consider certain information. The act requires the board to consider input from the council. APPROVED by Governor June 6, 2024 EFFECTIVE August 7, 2024(Note: This summary applies to this bill as enacted.)
Governor Signed
Sent to the Governor
Signed by the Speaker of the House
Signed by the President of the Senate
House Third Reading Passed - No Amendments
House Second Reading Special Order - Passed - No Amendments
House Second Reading Laid Over Daily - No Amendments
House Committee on Health & Human Services Refer Unamended to House Committee of the Whole
Introduced In House - Assigned to Health & Human Services
Senate Third Reading Passed - No Amendments
Senate Second Reading Special Order - Passed - No Amendments
Senate Committee on State, Veterans, & Military Affairs Refer Unamended - Consent Calendar to Senate Committee of the Whole
Introduced In Senate - Assigned to State, Veterans, & Military Affairs
| Bill Text Versions | Format |
|---|---|
| Signed Act (06/06/2024) | |
| Final Act (05/16/2024) | |
| Rerevised (05/05/2024) | |
| Revised (05/04/2024) | |
| Reengrossed (04/23/2024) | |
| Engrossed (04/22/2024) | |
| Introduced (04/08/2024) | |
| Committee Amendment |
| Document | Format |
|---|---|
| Fiscal Note FN1 (04/15/2024) | |
| Fiscal Note FN2 (06/21/2024) |
Data on Open States is updated periodically throughout the day from the official website of the Colorado General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.